Towards an MMP-2-activated molecular agent for cancer imaging
File(s)MMP-Final-AuthorsCopy.pdf (868.68 KB) MMP-SupplementaryInformation-Final-AuthorsCopy.pdf (1.29 MB)
Accepted version
Accepted version
Author(s)
Cowell, sheena
Carroll, laurence
Lavdas, ioannis
Aboagye, eric
Vilar Compte, R
Type
Journal Article
Abstract
Matrix metalloproteinases (MMPs) have been identified as biomarkers for cancer, offering prognostic potential; however, non-invasive detection protocols are currently lacking. Herein, we describe the synthesis of a DOTA-containing peptide sequence that can be radiolabelled easily with 68Gallium or can be incorporated with gadolinium for possible MRI applications with clear selectivity for MMP-2 over other members of the MMP family, giving MMP-2 selective cleavage of the labelled peptides.
Date Issued
2017-12-04
Date Acceptance
2017-12-04
Citation
Dalton Transactions, 2017, 47, pp.1530-1534
ISSN
1477-9234
Publisher
Royal Society of Chemistry
Start Page
1530
End Page
1534
Journal / Book Title
Dalton Transactions
Volume
47
Copyright Statement
© The Royal Society of Chemistry 2017
Sponsor
Cancer Research UK
Engineering & Physical Science Research Council (EPSRC)
Grant Number
10337
EP/H005285/1
Subjects
0302 Inorganic Chemistry
0399 Other Chemical Sciences
Inorganic & Nuclear Chemistry
Publication Status
Published